Advertisement
U.S. Markets closed

IDEAYA Biosciences, Inc. (IDYA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
30.88+0.34 (+1.11%)
At close: 04:00PM EDT
30.88 0.00 (0.00%)
After hours: 04:02PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
11,961
23,385
50,931
27,941
19,538
-
Operating Expense
203,346
157,814
113,433
78,209
54,882
-
Operating Income
-191,385
-134,429
-62,502
-50,268
-35,344
-
Net Non Operating Interest Income Expense
37,646
21,468
3,847
506
849
-
Other Income Expense
-
-
-
-
-
8
Pretax Income
-153,739
-112,961
-58,655
-49,762
-34,495
-
Net Income Common Stockholders
-153,739
-112,961
-58,655
-49,762
-34,495
-
Diluted NI Available to Com Stockholders
-153,739
-112,961
-58,655
-49,762
-34,495
-
Basic EPS
-1.98
-1.96
-1.42
-1.41
-1.40
-
Diluted EPS
-1.98
-1.96
-1.42
-1.41
-1.40
-
Basic Average Shares
53,238
57,520
41,445
35,252
24,722
-
Diluted Average Shares
53,238
57,520
41,445
35,252
24,722
-
Total Operating Income as Reported
-191,385
-134,429
-62,502
-50,268
-35,344
-
Total Expenses
203,346
157,814
113,433
78,209
54,882
-
Net Income from Continuing & Discontinued Operation
-153,739
-112,961
-58,655
-49,762
-34,495
-
Normalized Income
-153,739
-112,961
-58,655
-49,762
-34,495
-
Interest Income
37,646
21,468
3,847
506
849
-
Net Interest Income
37,646
21,468
3,847
506
849
-
EBIT
-191,385
-134,429
-62,502
-50,268
-35,344
-
EBITDA
-187,156
-130,421
-58,987
-47,236
-33,963
-
Reconciled Depreciation
4,229
4,008
3,515
3,032
1,381
-
Net Income from Continuing Operation Net Minority Interest
-153,739
-112,961
-58,655
-49,762
-34,495
-
Normalized EBITDA
-187,156
-130,421
-58,987
-47,236
-33,963
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-